Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1749 studies found for:    (psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Condition: Negative Symptoms of Schizophrenia in Post-menopausal Women.
Interventions: Drug: Raloxifene;   Drug: Lactosa (placebo arm)
2 Recruiting Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo
3 Completed Clinical Estradiol Trial in Women With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: Estradiol
4 Completed Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Condition: Schizophrenia
Intervention: Drug: raloxifene
5 Completed Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo;   Drug: SEP-363856 Open Label
6 Completed A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo
7 Completed
Has Results
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Conditions: Obesity;   Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Naltrexone 25mg;   Other: Placebo
8 Completed Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
Conditions: Women With Recent Diagnosis of Schizophrenia;   Men With Recent Diagnosis of Schizophrenia;   Healthy Women;   Healthy Men
Intervention: Other: GENDER
9 Terminated Quality of Life (QOL) in Female Patient With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine, Risperidone
10 Recruiting Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Condition: Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: Placebo
11 Recruiting Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Lu AF35700 (10 mg/day);   Drug: Lu AF35700 (30 mg/day);   Drug: Quetiapine (Seroquel XR® 800 mg/day)
12 Completed Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
Conditions: Overweight;   Pregnancy;   Mental Disorder
Interventions: Drug: Sulph, Puls, Lyc, Lack t, Con, Sep, Nux v, Calc c, Phos;   Drug: Homeopathy and Nutritional oriented diet
13 Completed
Has Results
A Definitive Estrogen Patch Study (ADEPT)
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder(Not in Manic Phase)
Interventions: Drug: Estradiol;   Other: placebo
14 Completed Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Amisulpride;   Drug: Placebo
15 Completed Clinical Study Of Schizophrenia in Both Men and Women
Condition: Schizophrenia
Intervention: Drug: lamotrigine
16 Completed Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
Condition: Schizophrenia
Intervention: Drug: GSK1144814
17 Completed Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects
Condition: Schizophrenia
Intervention: Drug: SCA-136
18 Completed Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Conditions: Schizophrenia;   Bipolar Disorder;   Schizoaffective Disorder
Intervention: Behavioral: Genetic Counseling
19 Completed A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia
Condition: Schizophrenia
Interventions: Drug: JNJ-37822681;   Other: Placebo
20 Withdrawn Behavioral Health Services for Women Receiving Public Assistance
Condition: Mental Disorders
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.